New Research Paper titled "Manufactured Tissue-to-Tissue Barrier Chip for Modeling the Human Blood-Brain Barrier and Regulation of Cellular Trafficking."
2023-06-30
[Bio TV] Get an inside look at the mind of CEO YongTae Kim!
2023-06-27
[2023 MPS World Summit] MEPSGEN's participation in 2023 MPS World Summit
2023-06-23
[CVB 2023] MEPSGEN's participation in CVB2023
2023-06-16
Exclusive interview with Dr. Robert Langer, founder of Moderna, and YongTae Kim, CEO of Mepsgen, leading domestic MPS (microphysiological systems) Innovator.
2023-06-09
Dr. Robert Langer Engages in Discussion with MEPSGEN CEO YongTae Kim on the "Strength and Potential of K-Biotech" at Bio USA 2023 Satellite Event KBTP 2023
2023-06-08
Company Presentation at Bio International Convention 2023_MEPSGEN
2023-06-07
K-Bio 544 Companies Converge in Boston, USA... Accelerating Global Expansion.
[BIO International Convention 2023] Come visit us at Booth #2464 (The Korea Pavilion)
2023-06-05
[BIO USA 2023] Korea Biotech Partnership _ Strength and Potential of K-biotech
2023-06-02
MEPSGEN Launches LNP Production Platform...Details Are Unveiled at BIO Conventional
MEPSGEN signs MOU with CELLARTGEN
2023-05-25
MEPSGEN signs MOU with CorestemChemon
2023-05-19
MEPSGEN signs MOU with Woojung Bio
2023-05-18
Come and say hello to MEPSGEN at the BIO KOREA 2023
2023-05-09
MEPSGEN, developing new medicines using human organs-on-chips technology
2023-02-13
YongTae Kim(CEO of MEPSGEN) is attending 'MPS and Beyond symposium'
2023-02-08
Online seminar : 'Microphysiological Barrier System for Drug Development'
2023-02-06
2022 13th Korean Tissue Engineering and Regenerative Medicine Society.
2022-12-09
MEPSGEN is attending the 2022 Korean BioChip Society Fall Conference in Jeju, November 2-4.
2022-11-02
